Cargando…
Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial
Tetrodotoxin (TTX) has emerged as a potentially efficacious agent for chemotherapy-induced neuropathic pain (CINP), a prevalent, debilitating condition often resistant to analgesics. This randomized, double-blind, dose-finding study was undertaken to explore safety and trends in efficacy of four TTX...
Autores principales: | Goldlust, Samuel A., Kavoosi, Mojgan, Nezzer, Jennifer, Kavoosi, Mehran, Korz, Walter, Deck, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064362/ https://www.ncbi.nlm.nih.gov/pubmed/33805908 http://dx.doi.org/10.3390/toxins13040235 |
Ejemplares similares
-
Safety, Tolerability, Pharmacokinetics, and Concentration-QTc Analysis of Tetrodotoxin: A Randomized, Dose Escalation Study in Healthy Adults
por: Kavoosi, Mojgan, et al.
Publicado: (2020) -
Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial
por: Hagen, Neil A., et al.
Publicado: (2017) -
Randomized, Double‐Blind, Placebo‐Controlled Trial of Intraarticular Trans‐Capsaicin for Pain Associated With Osteoarthritis of the Knee
por: Stevens, Randall M., et al.
Publicado: (2019) -
Tetrodotoxin, a Potential Drug for Neuropathic and Cancer Pain Relief?
por: González-Cano, Rafael, et al.
Publicado: (2021) -
The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial
por: Sanjari, Mojgan, et al.
Publicado: (2016)